BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9399664)

  • 1. Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells.
    Heike Y; Takahashi M; Ohira T; Naruse I; Hama S; Ohe Y; Kasai T; Fukumoto H; Olsen KJ; Podack EE; Saijo N
    Int J Cancer; 1997 Dec; 73(6):844-9. PubMed ID: 9399664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    Gene Ther; 1994 Jul; 1(4):269-75. PubMed ID: 7584091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
    Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Ohira T; Miura K; Nishio K; Saijo N
    Int J Cancer; 1993 Feb; 53(3):432-7. PubMed ID: 8428797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
    Ohira T; Ohe Y; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():48-51. PubMed ID: 1306238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.
    Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC
    Blood; 1997 Apr; 89(7):2529-36. PubMed ID: 9116299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.
    Li H; Jiang HJ; Ma MQ; Wei F; An XM; Ren XB
    Cancer Biother Radiopharm; 2007 Dec; 22(6):790-8. PubMed ID: 18158770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.
    Du G; Ye L; Zhang G; Dong Q; Liu K; Tian J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1727-36. PubMed ID: 22699929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of specific active immunization against murine melanoma using recombinant cytokines.
    Stidham KR; Ricci WM; Vervaert C; Abdel-Wahab Z; Seigler HF; Darrow TL
    Surg Oncol; 1996; 5(5-6):221-9. PubMed ID: 9129134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
    Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
    Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
    Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
    Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
    Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
    Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy.
    Bai F; Niu Z; Tian H; Li S; Lv Z; Zhang T; Ren G; Li D
    Immunol Lett; 2014; 159(1-2):36-46. PubMed ID: 24613899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
    Bahrambeigi V; Ahmadi N; Salehi R; Javanmard SH
    Immunol Invest; 2015; 44(3):216-36. PubMed ID: 25565576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.